December 2023 FDA Recall Americaine by Insight Pharmaceuticals Llc, A Prestige Consumer Healthcare Company
D-0236-2024 - Chemical Contamination

This Class I drug recall was voluntarily initiated by Insight Pharmaceuticals Llc, A Prestige Consumer Healthcare Company on December 21, 2023 for the product Americaine. The FDA reported the reason for recall as chemical contamination. The product was distributed Nationwide and the recall is currently completed.

Recall Number: D-0236-2024

Reason for Recall
Chemical Contamination: presence of benzene
Initiated
12-21-2023
Reported
01-24-2024
Quantity
34,704 cans

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Nationwide in the USA
Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight Pharmaceuticals Corp. Tarrytown, NY 10591, USA, A Prestige Consumer Healthcare company. Made in India. NDC 63736-378-02, Can UPC 3 63736 37882 0; Case UPC 1 03 63736 37882 7

Batch or Lot Expiration Information

Lot# 1A16420, exp. date 01/31/2025

Affected Packages Involved in this Recall